EverPoint Asset Management’s MacroGenics MGNX Stock Holding History

EverPoint Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.23M	Sell	60,000 -240,000	-80%	-$6.04M	0.02%	361
2016 Q3	$8.97M	Sell	300,000 -100,000	-25%	-$2.97M	0.16%	166
2016 Q2	$10.8M	Buy	400,000 +100,000	+33%	+$2.26M	0.21%	130
2016 Q1	$5.63M	Sell	300,000 -258,647	-46%	-$4.92M	0.11%	207
2015 Q4	$17.3M	Buy	558,647 +98,647	+21%	+$3M	0.36%	81
2015 Q3	$9.85M	Buy	460,000 +160,000	+53%	+$5.02M	0.26%	110
2015 Q2	$11.4M	Sell	300,000 -250,000	-45%	-$8.22M	0.21%	152
2015 Q1	$17.3M	Buy	550,000 +150,000	+38%	+$5.08M	0.33%	84
2014 Q4	$14M	Buy	400,000 +10,000	+3%	+$249K	0.32%	108
2014 Q3	$8.15M	Buy	390,000 +190,000	+95%	+$3.93M	0.19%	180
2014 Q2	$4.35M	Buy	+200,000	New	+$4.2M	0.09%	290

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's MGNX Position: Q4 2016 in Review

EverPoint Asset Management reduced its MacroGenics (MGNX) stake by 80% in Q4 2016, selling an estimated $6.04M and leaving 60,000 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #361.

EverPoint Asset Management first reported a position in MGNX in Q2 2014 and has held it in 11 quarters since. The position peaked at $17.3M in Q4 2015. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

EverPoint Asset Management held 60,000 shares of MacroGenics worth $1.23M as of Q4 2016.
EverPoint Asset Management sold 240,000 MacroGenics shares in Q4 2016, an estimated $6.04M.
MacroGenics made up 0.02% of EverPoint Asset Management's portfolio in Q4 2016, its #361 holding.
EverPoint Asset Management first reported a position in MacroGenics in Q2 2014 and has held it in 11 quarters since.
EverPoint Asset Management's MacroGenics position peaked at $17.3M in Q4 2015.
131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.